US7629384B2
(en)
*
|
1997-09-17 |
2009-12-08 |
Strategic Science & Technologies, Llc |
Topical delivery of L-arginine to cause beneficial effects
|
US7914814B2
(en)
*
|
1997-09-17 |
2011-03-29 |
Strategic Science & Technologies, Llc |
Topical delivery of arginine of cause beneficial effects
|
EP1027045A4
(en)
*
|
1997-10-31 |
2004-12-08 |
Arch Dev Corp |
METHODS AND COMPOSITIONS FOR REGULATING 5-ALPHA-REDUCTASE ACTIVITY
|
US7220427B2
(en)
*
|
1998-07-08 |
2007-05-22 |
Oryxe |
Mixture for transdermal delivery of low and high molecular weight compounds
|
US6946144B1
(en)
*
|
1998-07-08 |
2005-09-20 |
Oryxe |
Transdermal delivery system
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
ITMI991894A1
(it)
*
|
1999-09-09 |
2001-03-09 |
Carlo Ghisalberti |
Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
|
DE10009424A1
(de)
*
|
2000-02-28 |
2001-09-06 |
Henkel Kgaa |
Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung
|
US20060121103A1
(en)
*
|
2000-05-11 |
2006-06-08 |
Kenneth Kirby |
Transdermal delivery system
|
FR2811566B1
(fr)
*
|
2000-07-13 |
2003-01-17 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine
|
FR2811562B1
(fr)
*
|
2000-07-13 |
2003-03-07 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et un isoflavonoide
|
AU2001282064B2
(en)
|
2000-08-03 |
2007-02-01 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
FR2812873B1
(fr)
|
2000-08-11 |
2003-08-01 |
Barry Callebaut France |
Procede de production de polyphenols a partir de feves de cacao
|
DE60134702D1
(de)
|
2000-08-16 |
2008-08-21 |
Unilever Nv |
Mischungen von Isoflavonen und Flavonen
|
EP1180331B1
(en)
*
|
2000-08-16 |
2008-07-09 |
Unilever N.V. |
Blends of isoflavones and flavones
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
FR2815858B1
(fr)
*
|
2000-10-26 |
2003-12-12 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et un agent susceptible d'inhiber l'irritation d'origine neurogene
|
CN1262274C
(zh)
*
|
2000-11-14 |
2006-07-05 |
生命健康科学有限公司 |
磷酸盐衍生物复合物
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
FR2818148B1
(fr)
*
|
2000-12-15 |
2005-06-24 |
Oreal |
Composition,notamment cosmetique, renfermant, la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un isoflavonoide
|
FR2818135B1
(fr)
|
2000-12-15 |
2003-02-14 |
Oreal |
Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins un carotenoide
|
US6607735B2
(en)
|
2000-12-21 |
2003-08-19 |
Johnson & Johnson Consumer Companies, Inc. |
Method for reducing the appearance of dark circles under the eyes
|
NL1017333C2
(nl)
*
|
2001-02-12 |
2002-08-13 |
Gent Natural Products Van |
Cosmetisch resp. farmaceutisch preparaat.
|
US6589591B1
(en)
*
|
2001-07-10 |
2003-07-08 |
Baylor College Of Medicine |
Method for treating medical devices using glycerol and an antimicrobial agent
|
BR0211673A
(pt)
*
|
2001-07-27 |
2004-07-13 |
Vital Health Sciences Pty Ltd |
Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
|
CA2459647A1
(en)
*
|
2001-08-20 |
2003-02-27 |
University Of Virginia Patent Foundation |
Use of s-nitrosothiol signaling to treat disordered control of breathing
|
US8795716B2
(en)
|
2001-10-01 |
2014-08-05 |
The Procter & Gamble Company |
Skin care compositions on a thin sanitary napkin
|
WO2003049774A1
(en)
*
|
2001-12-13 |
2003-06-19 |
Vital Health Sciences Pty Ltd |
Transdermal transport of compounds
|
US20030199581A1
(en)
*
|
2002-03-13 |
2003-10-23 |
Seligson Allen L. |
Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses
|
ES2425392T3
(es)
|
2002-03-20 |
2013-10-15 |
Mannkind Corporation |
Cartucho para un aparato de inhalación
|
US7235249B2
(en)
|
2002-03-28 |
2007-06-26 |
The Procter & Gamble Company |
Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
|
DE10228680A1
(de)
*
|
2002-06-27 |
2004-01-22 |
Holden Development Limited, Tortola |
Grundlage für transdermale Formulierungen (PTF)
|
US7099713B2
(en)
|
2002-06-28 |
2006-08-29 |
Battelle Memorial Institute |
Skin conduction and transport systems
|
AU2002950713A0
(en)
*
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
US20040062794A1
(en)
*
|
2002-09-30 |
2004-04-01 |
Lee Shulman |
17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
|
US9035123B2
(en)
|
2002-10-01 |
2015-05-19 |
The Procter & Gamble Company |
Absorbent article having a lotioned topsheet
|
US20050008664A1
(en)
*
|
2002-12-06 |
2005-01-13 |
Board Of Regents, The University Of Texas System |
Compositions and methods related to lipid:emodin formulations
|
KR20050086954A
(ko)
*
|
2003-01-17 |
2005-08-30 |
바이탈 헬스 사이언시즈 피티와이 리미티드 |
항증식성 화합물
|
WO2004068107A2
(en)
*
|
2003-01-21 |
2004-08-12 |
Transform Pharmaceuticals, Inc |
Apparatus and method for transcellular testing
|
US7943166B2
(en)
|
2003-04-10 |
2011-05-17 |
Neurogesx, Inc. |
Methods and compositions for administration of TRPV1 agonists
|
US7052715B2
(en)
*
|
2003-04-11 |
2006-05-30 |
All Natural Fmg, Inc. |
Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
|
US7033998B2
(en)
*
|
2003-04-11 |
2006-04-25 |
All Natural Fmg, Inc. |
Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
|
AU2003901815A0
(en)
*
|
2003-04-15 |
2003-05-01 |
Vital Health Sciences Pty Ltd |
Phosphate derivatives
|
FR2855753B1
(fr)
*
|
2003-06-03 |
2007-09-14 |
Dermo Cosmologie Lab De |
Composition a base de diosgenine applicable par voie topique
|
US20050058673A1
(en)
|
2003-09-09 |
2005-03-17 |
3M Innovative Properties Company |
Antimicrobial compositions and methods
|
PT1670433E
(pt)
|
2003-10-10 |
2012-02-08 |
Ferring Bv |
Fórmula farmacológica transdérmica para a minimização de resíduos na pele
|
US6998109B1
(en)
|
2004-01-07 |
2006-02-14 |
Pearson Research & Development Limited |
Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
|
WO2005074946A1
(en)
*
|
2004-02-10 |
2005-08-18 |
Adenobio N.V. |
Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
|
US20050271597A1
(en)
*
|
2004-02-13 |
2005-12-08 |
Keith Alec D |
Prostate hypertrophy treatment composition and method
|
WO2005081964A2
(en)
*
|
2004-02-23 |
2005-09-09 |
Strategic Science & Technologies, Llc |
Topical delivery of a nitric oxide donor to improve body and skin appearance
|
WO2005084678A1
(en)
*
|
2004-03-03 |
2005-09-15 |
Vital Health Sciences Pty Ltd |
Alkaloid formulations
|
CA2561496A1
(en)
*
|
2004-04-02 |
2005-10-20 |
Baylor College Of Medicine |
Novel modification of medical prostheses
|
US20050226827A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Thienna Ho |
Skin lightening composition
|
WO2005102307A2
(en)
*
|
2004-04-19 |
2005-11-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US20110028548A1
(en)
*
|
2004-04-19 |
2011-02-03 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US9226909B2
(en)
|
2004-04-19 |
2016-01-05 |
Strategic Science & Technologies, Llc |
Beneficial effects of increasing local blood flow
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
ATE486064T1
(de)
|
2004-08-20 |
2010-11-15 |
Mannkind Corp |
Katalyse der diketopiperazinsynthese
|
PL1791542T3
(pl)
|
2004-08-23 |
2015-11-30 |
Mannkind Corp |
Sole diketopiperazyny do dostarczania leków
|
JP5449673B2
(ja)
*
|
2004-10-08 |
2014-03-19 |
クリヌベール、ファーマスーティカルズ、リミテッド |
対象者におけるメラニン形成を誘導するための組成物および方法
|
US9415034B2
(en)
*
|
2005-01-05 |
2016-08-16 |
National Defense Medical Center |
Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
|
ZA200707492B
(en)
*
|
2005-02-14 |
2009-02-25 |
Neurogesx Inc |
Device for delivery of TRPV1 agonists
|
CA2599424A1
(en)
*
|
2005-03-03 |
2006-09-08 |
Vital Health Sciences Pty Ltd |
Compounds having anti-cancer properties
|
KR20070113281A
(ko)
|
2005-03-10 |
2007-11-28 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
항미생물성 조성물 및 방법
|
WO2006099359A2
(en)
|
2005-03-10 |
2006-09-21 |
3M Innovative Properties Company |
Methods of reducing microbial contamination
|
US20060222690A1
(en)
*
|
2005-03-30 |
2006-10-05 |
Bley Keith R |
Low-concentration capsaicin patch and methods for treating neuropathic pain
|
US7563464B1
(en)
|
2005-04-22 |
2009-07-21 |
Bruce Eric Hudkins |
Treatment of mucosal membranes utilizing phytoestrogen
|
US7252834B2
(en)
*
|
2005-04-25 |
2007-08-07 |
Clemson University Research Foundation (Curf) |
Elastin stabilization of connective tissue
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
KR20080019228A
(ko)
*
|
2005-06-17 |
2008-03-03 |
바이탈 헬스 사이언시즈 피티와이 리미티드 |
하나 이상의 디 및/또는 모노-(전자전달제) 인산염 유도체또는 그의 착염을 함유하는 담체
|
AU2006290870B2
(en)
|
2005-09-14 |
2013-02-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
US20070185038A1
(en)
*
|
2005-09-30 |
2007-08-09 |
The Procter & Gamble Company |
Regulation of mammalian keratinous tissue using skin care actives
|
US8911751B2
(en)
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
US7920926B2
(en)
*
|
2005-12-09 |
2011-04-05 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
TW200800223A
(en)
*
|
2005-12-21 |
2008-01-01 |
Shire Pharmaceuticals Inc |
Transdermal delivery of meptazinol
|
US20070196301A1
(en)
|
2005-12-21 |
2007-08-23 |
L'oreal |
Cosmetic composition with a volumizing effect
|
FR2894811B1
(fr)
†
|
2005-12-21 |
2008-02-22 |
Oreal |
Composition cosmetique a effet volumateur
|
CA2631653A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Vital Health Sciences Pty Ltd. |
Compounds having cytokine modulating properties
|
BRPI0621248A2
(pt)
*
|
2006-01-17 |
2011-12-06 |
Majid Fotuhi |
medicamento e regime de dosagem para prevenção ou redução do risco de permanência ou progressão de demência através de administração de vitaminas especìficas e nsaid
|
EP2497484A3
(en)
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
US20090238763A1
(en)
|
2006-07-09 |
2009-09-24 |
Chongxi Yu |
High penetration compositions and uses thereof
|
US20090221703A1
(en)
|
2006-07-09 |
2009-09-03 |
Chongxi Yu |
High penetration composition and uses thereof
|
WO2008044095A1
(en)
|
2006-10-11 |
2008-04-17 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
|
JP4869347B2
(ja)
*
|
2006-07-14 |
2012-02-08 |
国立大学法人北海道大学 |
過冷却促進剤
|
DK2041068T3
(en)
|
2006-07-18 |
2017-02-27 |
Techfields Biochem Co Ltd |
POSITIVELY CHARGED, WATER SOLUBLE PRODRUGS OF IBUPROFEN WITH VERY FAST SKIN PENETRATION SPEED
|
PL2046727T3
(pl)
|
2006-07-25 |
2014-08-29 |
Techfields Biochem Co Ltd |
Dodatnio naładowane rozpuszczalne w wodzie proleki diklofenaku o bardzo szybkim stopniu przenikania przez skórę
|
PL2049482T3
(pl)
|
2006-08-08 |
2016-04-29 |
Techfields Biochem Co Ltd |
Dodatnio naładowane rozpuszczalne w wodzie proleki kwasów arylo- i heteroarylooctowych o bardzo dużej szybkości przenikania przez skórę
|
EP2061749B1
(en)
|
2006-09-03 |
2018-02-21 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate
|
PL2084132T3
(pl)
|
2006-09-03 |
2019-03-29 |
Techfields Biochem Co. Ltd |
Dodatnio naładowane rozpuszczalne w wodzie proleki z kwasów n-arylantranilowych z bardzo szybką penetracją skóry
|
US20080075793A1
(en)
*
|
2006-09-21 |
2008-03-27 |
Dunshee Wayne K |
Antiviral compositions and methods of use
|
EP2084124B9
(en)
*
|
2006-10-02 |
2015-07-01 |
Techfields Biochem Co. Ltd |
Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
|
US20080097557A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Apsara Medical Corporation |
Method and apparatus for carrying out the controlled heating of tissue in the region of dermis
|
AU2006349528B2
(en)
*
|
2006-10-23 |
2012-06-07 |
Ecolab Inc. |
Virucidal composition
|
US20100086495A1
(en)
*
|
2007-02-15 |
2010-04-08 |
Derma-Young Ltd. |
Compositions and methods for enhancing transmucosal delivery
|
AU2007354632B2
(en)
|
2007-06-04 |
2014-06-26 |
Techfields Inc |
Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses
|
JP2010539245A
(ja)
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
US20090155337A1
(en)
*
|
2007-11-12 |
2009-06-18 |
Endologix, Inc. |
Method and agent for in-situ stabilization of vascular tissue
|
GB0801119D0
(en)
|
2008-01-22 |
2008-02-27 |
Barry Callebaut Ag |
Composition
|
JP2011513220A
(ja)
*
|
2008-02-21 |
2011-04-28 |
ヴァトリックス・メディカル・インコーポレーテッド |
デリバリービヒクルと組み合わせた結合組織安定剤の適用による動脈瘤の処置
|
EP2271214B1
(en)
*
|
2008-03-28 |
2017-05-03 |
Particle Sciences, Inc. |
Pharmaceutical solutions and method for solubilizing therapeutic agents
|
DK2570147T3
(da)
|
2008-06-13 |
2018-01-29 |
Mannkind Corp |
Tørpulverinhalator og system til lægemiddelindgivelse
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
KR101628410B1
(ko)
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
KR101372658B1
(ko)
|
2008-06-25 |
2014-03-14 |
이엘씨 매니지먼트 엘엘씨 |
피부 및 신체 외관 개선 방법 및 조성물
|
US20100016833A1
(en)
*
|
2008-07-15 |
2010-01-21 |
Ogle Matthew F |
Devices for the Treatment of Vascular Aneurysm
|
TWI532497B
(zh)
|
2008-08-11 |
2016-05-11 |
曼凱公司 |
超快起作用胰島素之用途
|
BRPI0913499B1
(pt)
|
2008-09-15 |
2020-03-17 |
Laila Nutraceuticals |
Composições anti-inflamatórias sinergísticas compreendendo extratos de boswellia serrata
|
US20100119605A1
(en)
*
|
2008-11-12 |
2010-05-13 |
Isenburg Jason C |
Compositions for tissue stabilization
|
MX362949B
(es)
|
2008-12-04 |
2019-02-27 |
Yu Chongxi |
Composiciones de alta penetracion y sus aplicaciones.
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
US8734845B2
(en)
|
2009-06-12 |
2014-05-27 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
US11684624B2
(en)
|
2009-06-24 |
2023-06-27 |
Strategic Science & Technologies, Llc |
Treatment of erectile dysfunction and other indications
|
BRPI0925099A2
(pt)
|
2009-06-24 |
2018-10-16 |
Strategic Science & Tech Llc |
composição tópica contendo ibuprofeno
|
EP2445493A1
(en)
|
2009-06-24 |
2012-05-02 |
Strategic Science & Technologies, LLC |
Topical composition containing naproxen
|
US20110218517A1
(en)
*
|
2009-10-09 |
2011-09-08 |
Ogle Matthew F |
In vivo chemical stabilization of vulnerable plaque
|
US8444624B2
(en)
|
2009-10-19 |
2013-05-21 |
Vatrix Medical, Inc. |
Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
US9554994B2
(en)
|
2009-12-16 |
2017-01-31 |
Ecolab Usa Inc. |
Composition in form of a gel for the virucidal disinfection of mammalian skin
|
AU2011213557B2
(en)
|
2010-02-05 |
2015-05-07 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
EP2536288B1
(en)
|
2010-02-15 |
2022-06-22 |
Laila Nutraceuticals |
A novel boswellia low polar gum resin extract and its synergistic compositions
|
US8828377B2
(en)
|
2010-03-15 |
2014-09-09 |
Laila Nutraceuticals |
Boswellia oil, its fractions and compositions for enhancing brain function
|
CN102821791B
(zh)
|
2010-03-30 |
2015-06-17 |
磷肌酸有限公司 |
透皮递送贴剂
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
WO2012092523A1
(en)
|
2010-12-29 |
2012-07-05 |
Strategic Science & Technologies, Llc |
Systems and methods for treatment of allergies and other indications
|
CN103429247A
(zh)
|
2010-12-29 |
2013-12-04 |
战略科学与技术有限责任公司 |
勃起功能障碍和其它适应症的治疗
|
US8911468B2
(en)
|
2011-01-31 |
2014-12-16 |
Vatrix Medical, Inc. |
Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
|
TR201101374A1
(tr)
|
2011-02-14 |
2012-09-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Flurbiprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
EP2685992A4
(en)
|
2011-03-15 |
2014-09-10 |
Phosphagenics Ltd |
AMINO-QUINOLINES AS KINASE INHIBITORS
|
MY180552A
(en)
|
2011-04-01 |
2020-12-02 |
Mannkind Corp |
Blister package for pharmaceutical cartridges
|
TR201103183A1
(tr)
|
2011-04-01 |
2012-10-22 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Ketoprofen ve metilsülfonilmetanın topikal farmasötik bileşimleri.
|
TR201103770A1
(tr)
|
2011-04-19 |
2012-11-21 |
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ |
Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri.
|
JP2014516695A
(ja)
|
2011-05-18 |
2014-07-17 |
バトリックス・メディカル・インコーポレイテッド |
血管安定化用被覆バルーン
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
ES2885523T3
(es)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd Inc |
Formulaciones y terapias de reposición hormonal de combinación naturales
|
US20140315843A1
(en)
|
2011-12-16 |
2014-10-23 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Topical pharmaceutical compositions of thiocolchicoside and methylsulfonylmethane
|
CA3189252A1
(en)
|
2012-05-16 |
2013-11-21 |
Techfields Pharma Co., Ltd. |
High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9283241B2
(en)
|
2012-07-10 |
2016-03-15 |
Clemson University |
Treatment to render implants resistant to diabetes
|
CA2878457C
(en)
|
2012-07-12 |
2021-01-19 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014024193A1
(en)
*
|
2012-08-07 |
2014-02-13 |
Prodel Pharma Ltd. |
Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
BR112015023168B1
(pt)
|
2013-03-15 |
2021-08-10 |
Mannkind Corporation |
Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
|
CN114848614A
(zh)
|
2013-07-18 |
2022-08-05 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
CN113350324A
(zh)
*
|
2013-08-21 |
2021-09-07 |
协和大学 |
树状聚合物-白藜芦醇复合物
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
AU2015264003A1
(en)
|
2014-05-22 |
2016-11-17 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2016018993A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
US11510859B2
(en)
*
|
2015-07-16 |
2022-11-29 |
Marinomed Biotech Ag |
Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
EP3337482A4
(en)
*
|
2015-08-17 |
2019-03-20 |
Delivra Inc. |
TRANSDERMAL FORMULATIONS FOR THE DISTRIBUTION OF BERBERIN COMPOUNDS AND THEIR USE IN THE TREATMENT OF BERBER INDEPENDENT ILLNESSES AND DISORDERS
|
WO2017048807A1
(en)
|
2015-09-17 |
2017-03-23 |
Jrx Biotechnology, Inc. |
Approaches for improving skin hydration or moisturization
|
CA3007587C
(en)
|
2015-12-09 |
2023-12-05 |
Phosphagenics Limited |
Pharmaceutical formulation
|
US10688069B2
(en)
|
2016-03-31 |
2020-06-23 |
REV Pharmaceuticals LLC |
Sports health performance composition
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
CN106349206B
(zh)
*
|
2016-08-29 |
2018-09-21 |
珀莱雅化妆品股份有限公司 |
一种从毛喉鞘蕊花中提取福斯高林的制备方法
|
BR112019012946A2
(pt)
|
2016-12-21 |
2019-11-26 |
Avecho Biotechnology Ltd |
processo
|
US10385297B2
(en)
|
2017-03-16 |
2019-08-20 |
The Procter & Gamble Company |
Methods for making encapsulate-containing product compositions
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|